Focused on Cancer. Focused on Life.

Information Packet

Patient Handbook

To receive your free information packet that includes guides to cancer prevention, screening, treatment options and how to choose a cancer center, call (877) DFCI-BWH or
order it online.

Related Links

Advances in the Treatment of Genitourinary Cancers

Saturday, June 15, 2013 (New Date)
8:00 am – 12:30 pm
Dana-Farber Cancer Institute
Yawkey Center for Cancer Care
Boston, MA

Register Online Now

Offered by Dana-Farber/Brigham and Women's Cancer Center and Harvard Medical School Department of Continuing Education.

Quicklinks

Course Overview | Agenda | Faculty
Credits | Registration Information | Course Location

Course Overview

This continuing medical education course is intended to provide practicing clinicians with a deeper understanding of current and new treatment options for patients with genitourinary cancers. It is designed for medical and radiation oncologists, urologists, surgeons, and other interested clinicians. Through case presentations and discussion, faculty will share new advances in the field and discuss multidisciplinary approaches to treating prostate, bladder, testicular, and renal cancers. Faculty will also discuss how to evaluate treatment options, present current therapies, and discuss their effectiveness.

Learning Objectives

At the conclusion of this course, attendees will be able to: determine the most effective treatment options for patients with prostate cancer at various risk levels; evaluate the benefits of neoadjuvant and adjuvant therapy for invasive bladder cancer, and the role of drug therapy for metastatic bladder cancer; examine current treatment for stage 1 testicular cancer and apply in practice when appropriate; and initiate therapy for metastatic renal cell carcinoma for new and advanced stage disease based on current recommendations.

ACGME COMPETENCIES: This course is designed to enhance one or more of the following Accreditation Council of Graduate Medical Education competencies: Patient care • Medical knowledge • Interpersonal and communication skills.

The Genitourinary Oncology Program at Dana-Farber/Brigham and Women's Cancer Center

The Genitourinary Oncology Program is a multidisciplinary and multispecialty care and treatment center for patients with all genitourinary malignancies, including cancers of the prostate, testes, bladder and kidney. Through this program, referring physicians and their patients have access to tailored treatment plans based on the latest surgical, chemotherapy, and radiation treatment approaches, including access to NCI clinical trials.

Research is an integral part of our work in the Genitourinary Oncology Program. Physicians and researchers are engaged in studies involving prevention and early-detection strategies, assessment of new therapies, quality-of-life studies, and the analysis of tissue and blood samples to better understand the biology of the malignancies and relation to patient outcomes. This research enables us to provide more effective diagnostics and safer and more effective treatments to patients.

Agenda

8:00 am

Registration Check-in and Continental Breakfast

8:25 am

Welcome
Philip W. Kantoff, MD and Christopher J. Sweeney, MBBS

8:30 am

Who is an Active Surveillance Candidate?
Philip W. Kantoff, MD

8:45 am

Q&A

8:50 am

Optimal Therapy for High-Risk Prostate Cancer
Adam S. Kibel, MD and Paul L. Nguyen, MD

9:15 am

Q&A

9:20 am

Who Should Receive Adjuvant Radiation?
Anthony D'Amico, MD, PhD

9:35 am

Q&A

9:40 am

Management of Impotency and Incontinence Post Prostatectomy or Radiation: Strategies to Combat Treatment-Induced Impairments
Michael O'Leary, MD

9:55 am

Q&A

10:00 am

Landscape of Therapies for Castration Resistant Prostate Cancer (CRPC)
Mary-Ellen Taplin, MD

10:15 am

Q&A with Panel Discussion

10:30 am

Break

10:50 am

Radiation Options for Localized Bladder Cancer: Cystectomy and Non-Cystectomy Candidates
Clair J. Beard, MD

11:05 am

Q&A

11:10 am

The Role of Chemotherapy in Bladder Cancer: From Neoadjuvant to Second-Line Therapy
Lauren C. Harshman, MD

11:25 am

Q&A

11: 30 am

Care of Patients with Renal Cell Cancer: Discussion of VEGF TKI and mTORi and an Update on PD-1
Toni K. Choueiri, MD

11:45 am

Q&A

11:50 am

Management of Metastatic Testis Cancer
Mark Pomerantz, MD

12:05 pm

Q&A

12:10 pm – 12:30 pm

Closing Remarks
Philip W. Kantoff, MD and Christopher J. Sweeney, MBBS

Faculty

Philip W. Kantoff, MD, Course Co-Director
Chief Clinical Research Officer,
Chief, Division of Solid Tumor Oncology,
Director, Lank Center for Genitourinary Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine,
Harvard Medical School

Christopher J. Sweeney, MBBS, Course Co-Director
Clinical Director, Genitourinary Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine,
Harvard Medical School

Clair J. Beard, MD
Vice-Chair, Genitourinary Radiation Oncology,
Director, Testicular Cancer Center,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Radiation Oncology,
Harvard Medical School

Toni K. Choueiri, MD
Director, Kidney Cancer Center,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine,
Harvard Medical School

Anthony V. D'Amico, MD, PhD
Chair, Division of Genitourinary Radiation Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Radiation Oncology,
Harvard Medical School

Lauren C. Harshman, MD
Medical Oncologist, Genitourinary Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine,
Harvard Medical School

Adam S. Kibel, MD
Disease Center Leader, Urology,
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Surgery,
Harvard Medical School

Paul L. Nguyen, MD
Director of Prostate Brachytherapy,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Radiation Oncology,
Harvard Medical School

Michael O'Leary, MD
Surgical Oncologist, Genitourinary Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Surgery,
Harvard Medical School

Mark M. Pomerantz, MD
Medical Oncologist, Genitourinary Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine,
Harvard Medical School

Mary-Ellen Taplin, MD
Medical Oncologist, Genitourinary Oncology,
Dana-Farber/Brigham and Women's Cancer Center;
Associate Professor of Medicine
Harvard Medical School

HMS Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Essential Areas, Standards, and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

CME Credits

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.

The Harvard Medical School designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Registration Information

Registration fee is $50.00 (non-refundable) and includes course materials, continental breakfast and complimentary parking.

Register Online Now

To register by mail: Send a completed registration form and check made payable to DF/BWCC by April 5, 2013 to:

GU Oncology CME 2013
Dana-Farber Cancer Institute
Attn: Kamira Wooten
450 Brookline Avenue, OS 381
Boston, MA 02215

If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call 800-553-3787.

Course Location

This conference will take place at Dana-Farber's Yawkey Center for Cancer Care, 3rd Floor Dining Pavilion. Complimentary parking is available in the Dana-Farber garage located on Jimmy Fund Way. For direction, please visit: www.dana-farber.org/directions.

Professional Events

Continuing Medical Education

Find out more about upcoming CME courses.